Login / Signup

MicroRNA Profile Alterations in Parathyroid Carcinoma: Latest Updates and Perspectives.

Janusz MyśliwiecBeata PodgórskaMagdalena NiemiraMałgorzata SzelachowskaAdam Jacek KretowskiKatarzyna Siewko
Published in: Cancers (2022)
Parathyroid tumors are a genetically heterogenous group with a significant variability in clinical features. Due to a lack of specific signs and symptoms and uncertain histopathological criteria, parathyroid carcinomas (PCs) are challenging to diagnose, both before and after surgery. There is a great interest in searching for accurate molecular biomarkers for early detection, disease monitoring, and clinical management. Due to improvements in molecular pathology, the latest studies have reported that PC tumorigenesis is strongly linked to the epigenetic regulation of gene expression. MicroRNA (miRNA) profiling may serve as a helpful adjunct in distinguishing parathyroid adenoma (PAd) from PC and provide further insight into regulatory pathways involved in PTH release and parathyroid tumorigenesis. So far, only a few studies have attempted to show the miRNA signature for PC, and very few overlaps could be found between these relatively similar studies. A global miRNA downregulation was detected in PC compared with normal glands among differentially expressed miRNAs. This review summarizes changes in miRNA expression in PC and discusses the future research directions in this area.
Keyphrases
  • gene expression
  • case control
  • poor prognosis
  • dna methylation
  • transcription factor
  • cell proliferation
  • signaling pathway
  • current status
  • long non coding rna
  • single molecule
  • physical activity
  • depressive symptoms